PlacidWay and CellsTime expand partnership, combining AI-driven medical tourism with advanced stem cell therapies to ...

Super Brush LLC, a leading U.S. manufacturer of precision foam swabs and applicators, will exhibit at Analytica 2026 ...

By Christine WanjikuThere is no consistent evidence that genetically modified (GM) foods cause major human diseases, according to a new scientific review.The study, published in the journal GM Crops & ...

A new biosensor developed at the Department of Energy's Oak Ridge National Laboratory detects the emerging presence of fungus ...

Curative Biotechnology, Inc. (OTC: CUBTD) ("Curative” or the "Company”), a development-stage biomedical company focused on novel treatments for degenerative eye diseases, today announced a reverse ...

Galapagos intends to enter into a strategic collaboration with Gilead following Gilead's acquisition of Ouro Medicines New partnership structure would achieve meaningfully improved financial terms ...

ICNBC’s “Fast Money” team is joined by Insmed CEO Will Lewis to discuss the biotechnology company's outlook as its stock traded higher after positive trial results for its Arikayce drug.

The U.S. fishery and aquaculture industries are leaving money on the table, but a collection of investment groups and scientific institutions are working to change that via the recently launched North ...

For 4Q25, Nomura Healthcare Fund Institutional Class shares outperformed the Fund's benchmark, the Russell 3000 Healthcare ...

​Finch Therapeutics Group, Inc., a biotechnology company from Boston, enters bankruptcy along with three affiliates.

Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today ...

LENA Platform's four LDT products detect leukemia up to 41 months before symptoms — now live at alercell.com Alercell ...